Lewisham NHS Trust Adopts CSC's NextGen Pathology Solution

CSCLewisham Healthcare NHS Trust has become one of the first trusts to adopt CSC’s (NYSE: CSC) next-generation laboratory solution under a project to overhaul cellular pathology services across the new organization, formed by the merger of acute and community services in Lewisham.

Under a three-year contract won in open tender during the first quarter of CSC fiscal year 2013, CSC’s Healthcare Group will replace a Radius system for cellular pathology with its current laboratory solution. The agreement will immediately allow doctors to request cellular pathology tests and view all results online.

As an early adopter, Lewisham will also use current NextGen modules for cellular pathology and mortuary plus tools for vital cancer registry reporting.

The move supports calls for modern, efficient pathology services across the 450-bed University Hospital Lewisham and ten community health centres.

"Following this implementation we will be better placed to support the cellular pathology services now being offered across the trust in a more effective and efficient manner," said Alex Singer, Lewisham’s pathology manager. "CSC's laboratory solution is known for being robust and flexible. Having a solution that is reliable, easy to maintain and easy to customize was vital. It also allows us to develop and test new interfaces without impacting the core system or existing users and migrate gradually to CSC’s next-generation solution."

"Our NextGen solution is designed to meet demands on modern pathology services to do more for less and is another example of the work we are doing with our customers to develop solutions that meet their exact needs," said Andrea Fiumicelli, chief operating officer of CSC's Healthcare Group. "These and other innovations will help cement our position as the UK’s largest provider of laboratory information systems."

Lewisham Healthcare NHS Trust was formed in August 2010 after the merger of Lewisham Hospital NHS Trust and NHS Lewisham, and is one the first trusts to integrate acute and community services under one organisation.

Related news articles:

  • CSC's Profile

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 98,000 employees and reported revenue of $15.9 billion for the 12 months ended March 30, 2012.

Most Popular Now

AI Predictions for Colorectal Cancer: On…

Colorectal cancer (CRC) ranks second in leading causes of cancer-related deaths globally, according to the WHO. For the first time, researchers from Helmholtz Munich and the University of Technology Dresden...

Combining AI Models Improves Breast Canc…

Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the...

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

Healthcare Chatbot: Expand Support with …

The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...